Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Fenaux, P; Chomienne, C; Degos, L
   Treatment of acute promyelocytic leukaemia
   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
   
   P. Fenaux et al., "Treatment of acute promyelocytic leukaemia", BEST P R C, 14(1), 2001, pp. 153-174
2. Powell, BL
   Acute progranulocytic leukemia
   CURRENT OPINION IN ONCOLOGY
   
   B.L. Powell, "Acute progranulocytic leukemia", CURR OPIN O, 13(1), 2001, pp. 8-13
3. Benoit, G; Roussel, M; Pendino, F; Segal-Bendirdjian, E; Lanotte, M
   Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation
   ONCOGENE
   
   G. Benoit et al., "Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation", ONCOGENE, 20(49), 2001, pp. 7161-7177
4. Roussel, MJS; Lanotte, M
   Maturation sensitive and resistant t(15;17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes
   ONCOGENE
   
   M.J.S. Roussel e M. Lanotte, "Maturation sensitive and resistant t(15;17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes", ONCOGENE, 20(49), 2001, pp. 7287-7291
5. Nicolis, I; Deschamps, P; Curis, E; Corriol, O; Acar, V; Zerrouk, N; Chaumeil, JC; Guyon, F; Benazeth, S
   XAS applied to pharmaceuticals: drug administration and bioavailability
   JOURNAL OF SYNCHROTRON RADIATION
   
   I. Nicolis et al., "XAS applied to pharmaceuticals: drug administration and bioavailability", J SYNCHROTR, 8, 2001, pp. 984-986
6. Ozpolat, B; Lopez-Berestein, G; Mehta, K
   ATRA(ouble) in the treatment of acute promyelocytic leukemia
   JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
   
   B. Ozpolat et al., "ATRA(ouble) in the treatment of acute promyelocytic leukemia", J BIOL REG, 15(2), 2001, pp. 107-122
7. Du, YH; Ho, PC
   Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitiveand -resistant gynecological cancer cell lines
   CANCER CHEMOTHERAPY AND PHARMACOLOGY
   
   Y.H. Du e P.C. Ho, "Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitiveand -resistant gynecological cancer cell lines", CANC CHEMOT, 47(6), 2001, pp. 481-490
8. Wu, WS; Vallian, S; Seto, E; Yang, WM; Edmondson, D; Roth, S; Chang, KS
   The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases
   MOLECULAR AND CELLULAR BIOLOGY
   
   W.S. Wu et al., "The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases", MOL CELL B, 21(7), 2001, pp. 2259-2268
9. Nabhan, C; Mehta, J; Tallman, MS
   The role of bone marrow transplantation in acute promyelocytic leukemia
   BONE MARROW TRANSPLANTATION
   
   C. Nabhan et al., "The role of bone marrow transplantation in acute promyelocytic leukemia", BONE MAR TR, 28(3), 2001, pp. 219-226
10. Shearer, PD; Pui, CH
    The walls of a spacious room
    MEDICAL AND PEDIATRIC ONCOLOGY
    
    P.D. Shearer e C.H. Pui, "The walls of a spacious room", MED PED ONC, 36(2), 2001, pp. 312-313
11. Rego, EM; Pandolfi, PP
    Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models
    SEMINARS IN HEMATOLOGY
    
    E.M. Rego e P.P. Pandolfi, "Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models", SEM HEMATOL, 38(1), 2001, pp. 54-70
12. Burkham, J; Coen, DM; Hwang, CBC; Weller, SK
    Interactions of herpes simplex virus type 1 with ND10 and recruitment of PML to replication compartments
    JOURNAL OF VIROLOGY
    
    J. Burkham et al., "Interactions of herpes simplex virus type 1 with ND10 and recruitment of PML to replication compartments", J VIROLOGY, 75(5), 2001, pp. 2353-2367
13. Kogan, SC; Brown, DE; Shultz, DB; Truong, BTH; Lallemand-Breitenbach, V; Guillemin, MC; Lagasse, E; Weissman, IL; Bishop, JM
    BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRAR alpha) to block neutrophil differentiation and initiate acute leukemia
    JOURNAL OF EXPERIMENTAL MEDICINE
    
    S.C. Kogan et al., "BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRAR alpha) to block neutrophil differentiation and initiate acute leukemia", J EXP MED, 193(4), 2001, pp. 531-543
14. Lengfelder, E; Hehlmann, R; Buchner, T
    Current therapeutic concept of acute promyelocytic leukaemia
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    
    E. Lengfelder et al., "Current therapeutic concept of acute promyelocytic leukaemia", DEUT MED WO, 126(39), 2001, pp. 1073-1079
15. Douer, D
    Transcription therapy for acute promyelocytic leukaemia
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    D. Douer, "Transcription therapy for acute promyelocytic leukaemia", EXPERT OP I, 9(2), 2000, pp. 329-346
16. Takahashi, N; Kubo, Y; Iwahori, A; Kawai, K; Fukui, T
    Induction of apoptosis in the human promyelocytic leukemia cell line HL60 by falconensone A and its derivatives, new polyenes
    BIOLOGICAL & PHARMACEUTICAL BULLETIN
    
    N. Takahashi et al., "Induction of apoptosis in the human promyelocytic leukemia cell line HL60 by falconensone A and its derivatives, new polyenes", BIOL PHAR B, 23(6), 2000, pp. 748-754
17. Zhang, TC; Cao, EH; Li, JF
    A laser scanning confocal microscopy method - Simultaneous detection of intracellular Ca2+ and apoptosis using Fluo-3 and Hoechst 33342
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
    
    T.C. Zhang et al., "A laser scanning confocal microscopy method - Simultaneous detection of intracellular Ca2+ and apoptosis using Fluo-3 and Hoechst 33342", ANAL QUAN C, 22(2), 2000, pp. 93-97
18. Cheson, BD; Zwiebel, JA; Dancey, J; Murgo, A
    Novel therapeutic agents for the treatment of myelodysplastic syndromes
    SEMINARS IN ONCOLOGY
    
    B.D. Cheson et al., "Novel therapeutic agents for the treatment of myelodysplastic syndromes", SEMIN ONCOL, 27(5), 2000, pp. 560-577
19. Rego, EM; He, LZ; Warrell, RP; Wang, ZG; Pandolfi, PP
    Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RAR alpha and PLZF-RAR alpha oncoproteins
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    E.M. Rego et al., "Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RAR alpha and PLZF-RAR alpha oncoproteins", P NAS US, 97(18), 2000, pp. 10173-10178
20. Kizaki, M; Fukuchi, Y; Ikeda, Y
    A novel retinoic acid-resistant acute promyelocytic leukemia model in vitro and in vivo (review)
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    
    M. Kizaki et al., "A novel retinoic acid-resistant acute promyelocytic leukemia model in vitro and in vivo (review)", INT J MOL M, 4(4), 1999, pp. 359-364
21. Deng, YP; Lin, C; Zheng, J; Liang, X; Chen, JP; Fu, M; Xiao, PG; Wu, M
    Mechanisms of arsenic trioxide induced apoptosis of human cervical cancer HeLa cells and protection by Bcl-2
    SCIENCE IN CHINA SERIES C-LIFE SCIENCES
    
    Y.P. Deng et al., "Mechanisms of arsenic trioxide induced apoptosis of human cervical cancer HeLa cells and protection by Bcl-2", SCI CHINA C, 42(6), 1999, pp. 635-643
22. Kogan, SC; Bishop, JM
    Acute promyelocytic leukemia: from treatment to genetics and back
    ONCOGENE
    
    S.C. Kogan e J.M. Bishop, "Acute promyelocytic leukemia: from treatment to genetics and back", ONCOGENE, 18(38), 1999, pp. 5261-5267
23. He, LZ; Merghoub, T; Pandolfi, PP
    In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications
    ONCOGENE
    
    L.Z. He et al., "In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications", ONCOGENE, 18(38), 1999, pp. 5278-5292
24. Hu, J; Shen, ZX; Sun, GL; Chen, SJ; Wang, ZY; Chen, Z
    Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    J. Hu et al., "Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution", INT J HEMAT, 70(4), 1999, pp. 248-260
25. Gianni, M; de The, H
    In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RAR alpha protein and the PML retargeting on PML-nuclear bodies
    LEUKEMIA
    
    M. Gianni e H. de The, "In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RAR alpha protein and the PML retargeting on PML-nuclear bodies", LEUKEMIA, 13(5), 1999, pp. 739-749
26. 
    Hematology in China
    HAEMATOLOGICA
    
    HAEMATOLOG, 84(3), 1999, pp. 193-193
27. Wang, ZY; Sun, GL; Shen, ZX; Chen, SJ; Chen, Z
    Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application
    CHINESE MEDICAL JOURNAL
    
    Z.Y. Wang et al., "Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application", CHIN MED J, 112(11), 1999, pp. 963-967
28. Tallman, MS
    The thrombophilic state in acute promyelocytic leukemia
    SEMINARS IN THROMBOSIS AND HEMOSTASIS
    
    M.S. Tallman, "The thrombophilic state in acute promyelocytic leukemia", SEM THROMB, 25(2), 1999, pp. 209-215
29. Estrov, Z; Manna, SK; Harris, D; Van, Q; Estey, EH; Kantarjian, HM; Talpaz, M; Aggarwal, BB
    Phenylarsine oxide blocks interleukin-1 beta-induced activation of the nuclear transcription factor NF-kappa B, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells
    BLOOD
    
    Z. Estrov et al., "Phenylarsine oxide blocks interleukin-1 beta-induced activation of the nuclear transcription factor NF-kappa B, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells", BLOOD, 94(8), 1999, pp. 2844-2853
30. TALLMAN MS
    THERAPY OF ACUTE PROMYELOCYTIC LEUKEMIA - ALL-TRANS-RETINOIC ACID ANDBEYOND
    Leukemia
    
    M.S. Tallman, "THERAPY OF ACUTE PROMYELOCYTIC LEUKEMIA - ALL-TRANS-RETINOIC ACID ANDBEYOND", Leukemia, 12, 1998, pp. 37-40
31. Lo Coco, F; Nervi, C; Avvisati, G; Mandelli, F
    Acute promyelocytic leukemia: a curable disease
    LEUKEMIA
    
    F. Lo Coco et al., "Acute promyelocytic leukemia: a curable disease", LEUKEMIA, 12(12), 1998, pp. 1866-1880
32. MULLER S; MILLER WH; DEJEAN A
    TRIVALENT ANTIMONIALS INDUCE DEGRADATION OF THE PML-RAR-ALPHA ONCOPROTEIN AND REORGANIZATION OF THE PROMYELOCYTIC LEUKEMIA NUCLEAR-BODIES IN ACUTE PROMYELOCYTIC LEUKEMIA NB4 CELLS
    Blood
    
    S. Muller et al., "TRIVALENT ANTIMONIALS INDUCE DEGRADATION OF THE PML-RAR-ALPHA ONCOPROTEIN AND REORGANIZATION OF THE PROMYELOCYTIC LEUKEMIA NUCLEAR-BODIES IN ACUTE PROMYELOCYTIC LEUKEMIA NB4 CELLS", Blood, 92(11), 1998, pp. 4308-4316
33. Kizaki, M; Muto, A; Kinjo, K; Ueno, H; Ikeda, Y
    Application of heavy metal and cytokine for differentiation-inducing therapy in acute promyelocytic leukemia
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    M. Kizaki et al., "Application of heavy metal and cytokine for differentiation-inducing therapy in acute promyelocytic leukemia", J NAT CANC, 90(24), 1998, pp. 1906-1907